The Opioid Epidemic

Discussion in 'The Mainboard' started by steamengine, Jun 23, 2017.

  1. Pharm

    Pharm Right Handed
    Donor
    Florida State SeminolesAtlanta HawksAtlanta FalconsCalgary Flames

    During treatment, our facility was very anti marijuana for any reason because of lack of testing and the fact that it would be hard to determine DUI. We then found out that the facility had a large stake in a "weed breathalyze company"

    After all, this is still american healthcare, someone is going to be trying to make a profit somewhere.
     
  2. Prospector

    Prospector I am not a new member
    Arkansas Razorbacks

    State Drug Director on opioid crisis: ‘What we have been doing … is not working’

    State Drug Director Kirk Lane says the state and nation aren’t doing enough to combat the nation’s opioid epidemic, while the U.S. House of Representatives is passing a flurry of bills to combat the problem.

    “The biggest thing that Arkansas needs to do is be adaptable to change. What we have been doing for a long time is not working,” Lane said during an opioid summit at the University of Arkansas at Little Rock on Monday (June 18).

    The summit was organized by the office of U.S. Rep. French Hill, R-Little Rock, and featured two panel discussions. One of those included Lane; Hill; Commander Karen Hearod, regional administrator for the federal Substance Abuse and Mental Health Services Administration (SAMHSA); and Jim Tom Bell, a member of the board of directors of the Quapaw House addiction treatment facility. Arkansas Surgeon General Dr. Greg Bledsoe moderated the discussions.

    According to the National Institute on Drug Abuse, deaths nationwide from drug overdoses increased from 16,849 in 1999, when half were opioid related, to 63,632 in 2016, when two-thirds were. The 63,632 divided by 365 equals more than 174 deaths per day.

    “If we loaded up an airplane with 175 people and crashed it every day, how long would it take until we shut down the airline?” Lane asked.

    Lane said Arkansas had the second highest opioid prescription rate in the country with 114.6 prescriptions for every 100 people in 2016. That number has been above 100 since 2007. Eight of 10 heroin users started by using prescription medication. And yet the state has not yet adopted Centers for Disease Control and Prevention opioid prescription guidelines that were released in 2016.

    There have been some successes. Lane said Arkansas collected the third most unneeded prescription drugs per capita in the Drug Enforcement Administration’s National Drug Take Back Initiative. In addition to annual events, there are also hundreds of 24-hour sites statewide, compared to just three in 2010. The state has distributed 3,300 opioid overdose-combatting naloxone kits in the last 16 months to law enforcement officers, contributing to 102 saved lives. Lane said naloxone helps addicts survive, giving them a chance to recover during a time when they may be open to change but need outside support.

    CONGRESS PASSES FLURRY OF LEGISLATION
    Hill said the House of Representatives passed 36 bills last week related to the opioid epidemic and could pass another 21 this week. The bills cover a range of issues, including law enforcement, criminal justice, and prevention and treatment.

    Hill said some of the bills may eventually become law. Many have a bipartisan consensus, and some have Senate companion bills.

    One bill would provide additional resources to the United States Postal Service to use screening technology to interdict fentanyl coming via the mail through Mexico and Canada, a primary path into the country. Fentanyl is a powerful synthetic opioid capable of killing many people in small amounts.

    Earlier this year, Congress appropriated an additional $4 billion in its omnibus spending package for combating the opioid epidemic.

    Hill said drugs, drug addiction, and mental health issues combined are the “biggest social crisis I think we have domestically in our country.”

    Commander Hearod with SAMHSA said the health system needs an integrated approach and an infrastructure to deal with the opioid crisis rather than the patchwork system that exists now.

    She said a stigma exists with drug abuse. While a community might rally around a medical patient, a treatment patient does not receive that same support. She described one addict whose father came home from a heart attack to casseroles and offers of car rides for his mother. Years later, the son did not receive that same reception.

    “This same gentleman, when he came home from treatment, there was nothing, right? Nobody came to the house. Nobody brought a casserole,” she said.

    According to the National Institute on Drug Abuse, deaths nationwide from drug overdoses increased from 16,849 in 1999, when half were opioid related, to 63,632 in 2016, when two-thirds were. The 63,632 divided by 365 equals more than 174 deaths per day.

    “If we loaded up an airplane with 175 people and crashed it every day, how long would it take until we shut down the airline?” Lane asked.
     
  3. Bruce Wayne

    Bruce Wayne Billionaire Playboy
    Donor
    Michigan Wolverines

  4. AIP

    AIP Spilled the Paint
    Donor
    Temple OwlsPhiladelphia PhilliesPhiladelphia EaglesPhiladelphia Flyers

    Not just the lives lost but also the lives ruined and family destroyed
     
    TrustyPatches, tjsblue, dump and 3 others like this.
  5. Gunners

    Gunners Nicking a living
    Donor
    Ohio State BuckeyesBaltimore OriolesWashington WizardsWashington RedskinsWashington CapitalsArsenal

    Seemed to be a hot topic for a couple months, we ended up doing nothing, people got a new topic to get worked up about, and it just keeps getting worse. This fucking country right now
     
    Uncle Si, Luka, BudKilmer and 4 others like this.
  6. Lyrtch

    Lyrtch My second favorite meat is hamburger
    Staff Donor
    Clemson TigersAntifaAnarchy

    theres a bill sitting on trumps desk iirc

    based on a cursory read its nothing major but making Transport Authority test for fentanyl might be something
     
  7. Dex

    Dex Well-Known Member
    Clemson TigersCarolina Panthers

    We’re actively addressing locally with physicians and staff at myfacility and nationally with my company.

    Another component is that hospitals can’t use marijuana even in states where legal because the federal government is a hospital’s biggest payor
     
    Luka, Wu, Tiffin and 1 other person like this.
  8. Bruce Wayne

    Bruce Wayne Billionaire Playboy
    Donor
    Michigan Wolverines

  9. DUCKMOUTH

    DUCKMOUTH People don’t you know, don’t you know
    Donor
    Southern Mississippi Golden EaglesNew Orleans SaintsGrateful Dead

    I fear for my kids and the ease of access to these kinds of drugs as the get older.

    Also the way pop culture glorifies pharmaceuticals is scary for me as a parent of future teens.

    Why can’t we just go back to songs like I’ve e got 5 on it
     
    Luka and TC like this.
  10. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

  11. Bruce Wayne

    Bruce Wayne Billionaire Playboy
    Donor
    Michigan Wolverines

    Uhhhhh ya think

     
    tjsblue, Luka and Tiffin like this.
  12. RalfBully

    RalfBully #21
    Staff Donor TMB OG
    Michigan State SpartansDetroit PistonsDetroit LionsTiger Woods

    Florida going after CVS and Walgreens
     
  13. Emma

    Emma is a model
    Donor
    Wisconsin BadgersMilwaukee Brewers altMilwaukee BucksGreen Bay Packers

  14. spagett

    spagett Got ya, spooked ya
    Donor

    Kids, we took sacks to the face back in our day
     
  15. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

  16. Can I Spliff it

    Can I Spliff it Is Butterbean okay?
    Donor

  17. HuskerInMiami

    HuskerInMiami Well-Known Member
    Donor
    Miami DolphinsNebraska Cornhuskers

    Can you post the story in spoilers?
     
  18. Can I Spliff it

    Can I Spliff it Is Butterbean okay?
    Donor

    sure

    Purdue Pharma Family Had Heavy Hand in Opioid Marketing, Complaint Says
    Recently revealed internal emails suggest Sackler family involvement in sales and marketing efforts


    Purdue Pharma’s signature drug is OxyContin. PHOTO: GEORGE FREY/REUTERS
    8 COMMENTS
    By
    Sara Randazzo and
    Jared S. Hopkins
    Jan. 15, 2019 7:57 p.m. ET



    In early 2011, Purdue Pharma was gearing up to promote its newest opioid painkiller, Butrans. Richard Sackler, a board member, former president and second-generation member of the company’s controlling family, made his high expectations for sales clear.

    “I had hoped for better results,” he emailed sales staff after hearing about a week of prescriptions that doubled Purdue forecasts, new court documents show. “What else more can we do to energize the sales and grow at a faster rate?” he said after reviewing another weekly report, according to the documents.


    The internal emails emerged Tuesday in an amended complaint filed by Massachusetts Attorney General Maura Healey, who sued Purdue, eight Sackler family members and other board members and executives in June for allegedly contributing to the state’s opioid epidemic through its aggressive marketing of opioids. Massachusetts is one of at least 36 states to sue Purdue, along with more than 1,500 cities and counties, accusing the company of helping create a public health crisis that kills more than 100 Americans daily.

    The lawsuit was filed by Massachusetts Attorney General Maura Healey. PHOTO: BRIAN SNYDER/REUTERS
    The complaint, using information culled from company emails, presentations and handwritten notes, suggests Richard Sackler and other Sackler family members at times influenced the marketing of the company’s opioids, including its signature drug OxyContin. Those actions include Sackler family members poring over detailed sales reports, pressing its sales force to improve numbers and even attending sales pitches themselves, according to the complaint.

    Company staff informed the Sacklers about opioid-related deaths and other addiction issues, the complaint says, as well as doctors prescribing pills inappropriately.

    Purdue said Tuesday the amended complaint cherry-picks from the tens of millions of emails and documents the company has produced so far in the litigation and is “littered with biased and inaccurate characterizations.”

    A Purdue spokesman, speaking on behalf of the Sacklers, said the Sacklers declined to comment.

    The Sackler family has for years cultivated a persona as global benefactors of the arts and sciences, while avoiding speaking publicly about their ties to OxyContin and the wider opioid crisis.

    In Massachusetts, more than 11,000 people have died from opioid-related overdoses over the past decade. An attorney general investigation tied 671 of those to people who filled prescriptions for Purdue opioids, according to the complaint.

    Three Sackler brothers—Raymond, Arthur and Mortimer—helped build Purdue into a powerful drug company after buying its predecessor in 1952.


    OxyContin, approved by U.S. regulators in 1995, became the company’s breakthrough product and remains its biggest-selling drug. The company is still entirely owned by Sackler members through family-controlled trusts.

    Raymond’s son Richard became president in 1999. Known inside Purdue as “Dr. Richard,” he served as president until 2003 and remained a hands-on board director.

    At an OxyContin launch party, the complaint alleges, Richard Sackler told the audience that “the launch of OxyContin tablets will be followed by a blizzard of prescriptions that will bury the competition.”

    In 2001, after a federal prosecutor reported 59 deaths from OxyContin in a single state, Richard Sackler wrote to executives, “This is not too bad. It could have been far worse,” the complaint says. That same year, according to the complaint, he wrote in an email, “We have to hammer on the abusers in every way possible. They are the culprits and the problem. They are reckless criminals.”

    Most of the amended complaint focuses on Purdue’s marketing and activity starting in 2007, the year the company agreed to pay $600 million to resolve federal charges that it misled consumers. A handful of company officials also pleaded guilty to misdemeanor charges and were fined by more than $34 million. The Sacklers weren’t personally accused of any wrongdoing.

    In 2011, Richard Sackler asked to be sent into the field to shadow sales representatives, the complaint says. To overcome concerns that Mr. Sackler promoting opioids could be a compliance problem, staff said in an email cited in the complaint: “Richard needs to be mum and be anonymous.”

    After going along on the sales visit, the complaint alleges, “Richard argued to the Vice President of Sales that a legally required warning about Purdue’s opioids wasn’t needed. He asserted that the warning ‘implies a danger of untoward reactions and hazards that simply aren’t there.’ Richard insisted there should be ‘less threatening’ ways to describe Purdue opioids.”

    Purdue said Tuesday the complaint “irresponsibly and counterproductively casts every prescription of OxyContin as dangerous and illegitimate,” ignoring the approvals by the Food and Drug Administration and patients who rely on the medicine for severe chronic pain.

    Purdue is one of many drugmakers and wholesalers facing litigation over the opioid crisis. The companies have been engaged in settlement talks with state attorneys general and municipalities to reach a global resolution.

    The majority of the lawsuits don’t target the Sacklers specifically, but a handful name individual family members as defendants.

    In 2016, Forbes magazine ranked the Sackler family 19th among America’s richest families, with assets estimated at $13 billion. The family has become a regular figure in philanthropy, helping fund art exhibits including the Sackler Wing of the Metropolitan Museum of Art in New York and the Arthur M. Sackler Gallery at the Smithsonian Institution in Washington.

    About a year ago, the Stamford, Conn., company stopped promoting its opioid drugs to doctors and shed its sales force by more than half. It has donated money to developing and distributing opioid-overdose antidotes.
     
    Luka, Prospector and HuskerInMiami like this.
  19. Gunners

    Gunners Nicking a living
    Donor
    Ohio State BuckeyesBaltimore OriolesWashington WizardsWashington RedskinsWashington CapitalsArsenal

  20. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

    Look to your left, look to your right. If you didn't nod out yet then you're not on opioids
     
  21. Bruce Wayne

    Bruce Wayne Billionaire Playboy
    Donor
    Michigan Wolverines

    What a coincidence

     
    Lipp, The Hotch, blind dog and 7 others like this.
  22. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

  23. I imagine many of our "lawmakers" in Congress are heavily on the take from pharmaceutical companies. 60 minutes did a pretty interesting segment on a pharm company out in San Francisco (name escapes me at the moment) about 2 years ago. IIRC they basically accused the companies of paying off congressional leaders to look the other way while they were mass producing and distributing opioids. I work a side gig in a hospital here in central Florida where during the height of the pill mills, shit was out of control. We had so many heroin, Roxy/Oxy/morphine ODs daily and people coming in over and over for treatment it was ridiculous. Get one of them talking and they'd tell you all about how easy it was to get the stuff anytime they needed. Dealers, doctors, pain clinics, it didn't matter. They were supplying it in 100 count bottles like they were giving out Tylenol. This crisis will never go away as long as these pharm companies are paying off our government.
     
    Randy Bobandi and TC like this.
  24. Frank Martin

    Frank Martin tough love makes better posters
    Donor
    South Carolina GamecocksBaltimore OriolesBaltimore RavensLiverpool

    Are people going to suddenly stop doing drugs?
     
  25. Short answer, no. Long answer, I think if marijuana were legalized nationwide I think more people would use that than try some of the more potent drugs like the ones I listed. Furthermore, if MJ was legalized and the opiates were not as easy to get (the legal types made by the pharm companies), opiate use and abuse would tapir off, slowly.
     
  26. DUCKMOUTH

    DUCKMOUTH People don’t you know, don’t you know
    Donor
    Southern Mississippi Golden EaglesNew Orleans SaintsGrateful Dead

    Hopefully we can build this wall so we can stop the influx of drugs that are killing people.

    Oh wait... never mind they came fed ex from China or my doctor prescribed it
     
    blind dog likes this.
  27. Prospector

    Prospector I am not a new member
    Arkansas Razorbacks

    A Real Killing: How Greedy Corporate Pushers Caused the Opioid Crisis
    Purdue and other big Oxy peddlers now face trial in federal court.
    By Brian SaadyJanuary 23, 2019

    [​IMG]
    By Tero Vesalainen /Shutterstuck
    A federal judge has ruled that a massive lawsuit that blames drug manufacturers, distributors, and pharmacies for the American opioid epidemic will proceed to trial.

    “It is accurate to describe the opioid epidemic as a man-made plague, twenty years in the making. The pain, death, and heartache it has wrought cannot be overstated,” blasted U.S. District Judge Dan Polster of the Northern District of Ohio in his ruling last month.

    This federal trial will take place in September.
    The class action combines no fewer than 600 claims by local and state governments against the opioid industry. While the more cynical among us might think this is nothing but a cash grab by our nation’s prosecutors, the facts show that this is the least we can do to hold these corporate criminals accountable
    Take Purdue Pharma, the first manufacturer of OxyContin and the most high-profile defendant in this case. The company has reportedly made $35 billion from the sale of OxyContin since its introduction in 1995, mostly thanks to an early marketing campaign that sold the painkiller as a pill to “start with and to stay with” that was “virtually non-addictive.” Addiction, Purdue said, occurred with less than 1 percent of patients. Clinical trials have since contradicted that bold claim, but that hasn’t stopped Purdue or other manufacturers from pushing this lie for the last two decades. Meanwhile, some 200,000 people have died from overdoses of OxyContin or other prescription painkillers since 1999.

    This campaign of deception wasn’t limited to Purdue. A report by the Center for Public Integrity and the Associated Press found that, from 2012 to 2017, the top five opioid manufacturers gave more than $10 million to various seemingly independent, non-profit advocacy groups, which in turn promoted the painkillers.

    That doesn’t even include the collective $14 million spent by opioid manufacturers for advertisements in medical journals in 2011 alone. Nor does it include the thousands of doctors who accepted lucrative payments from opioid manufacturers for speaking engagements and consulting.

    Not coincidentally, an investigation by CNN and Harvard researchers demonstrated a correlation between the money drug companies paid to doctors and the significant numbers of opioids they prescribed to their patients. In some cases, doctors received six-figure compensations from drug companies.

    Hence, the current federal effort has a number of parallels to past lawsuits against tobacco companies. But the shameless promotion of opioids represents a new level of depravity. As far back as the 1930s, tobacco companies were hiring doctors to make false claims about cigarette smoking in advertisements. However, they never enlisted an army of well-paid doctors to actually prescribe their cigarettes.

    After OxyContin’s introduction in 1995, DEA officials began taking note of Purdue’s aggressive tactics, which were unprecedented for a Schedule II drug—including promotionally branded giveaways to professionals in the health care field. Alas, Rudy Giuliani and his consulting firm proved to be an ironic but highly effective advocate for their company. During his well-paid stint in 2002, Giuliani met with DEA officials on multiple occasions and convinced them to ease some planned restrictions on OxyContin.

    Two years later, Eric Holder, the former attorney general, while working for Covington & Burling, helped negotiate a meager $10 million settlement with the state of West Virginia over OxyContin. Importantly, that agreement allowed Purdue to withhold documents and testimony related to its marketing practices.

    Likewise, with Mary Jo White, the former U.S. attorney for the Southern District of New York, at their side, Purdue Pharma executives avoided serving prison time in 2007. The company and three executives were fined $630 million and sentenced to three years of probation and 400 hours of community service over their aggressive and deceptive marketing of the drug.

    Such a relatively light punishment clearly didn’t deter the company’s aggressive practices. By 2016, Purdue Pharma had increased its sales force to 700 reps, up from 300 in 2007. OxyContin’s sales peaked in 2010 with more than $3 billion of revenue.

    So Purdue Pharma has made in the range of over $35 billion in sales from OxyContin over the last 24 years. As a point of comparison, the world’s most notorious drug trafficker, Joaquín “El Chapo” Guzmán, generated an estimated $16 billion fortune, with only a portion of his drug empire derived from the profits of heroin.

    There is a legitimate place for prescription opioids in the health care industry. The problem is that companies such as Purdue have consistently fought legal battles to stymie transparency. That includes subpoenas related to their marketing campaigns and doctors with unusually high prescription rates.

    Over the years, many pill mill operators and shady doctors have been sent to prison for crimes related to prescription opioids. Yet the big fish at the top of the corporate hierarchy have yet to see the inside of a prison cell.

    Granted, the blame doesn’t fall solely on the manufacturers. Major pharmacy chains, such as Walgreens and CVS, have failed to properly monitor and report suspicious activity. For instance, a lawsuit filed by the state of Florida found that 2.2 million opioid pills were dispensed in a single Walgreens store in Hudson, a town of 12,000 people.

    Our nation’s drug distribution companies have also ignored glaring red flags. Last year, the U.S. House Committee on Energy and Commerce found that 780 million hydrocodone and oxycodone pills were sent to the state of West Virginia between 2007 and 2012. That’s 433 pills per person!

    The subsets within these statistics are even more outrageous. Case in point: over a nine-year period, McKesson and Cardinal Health delivered 12.3 million opioid pills to a single pharmacy in Mount Gay-Shamrock. Mind you, that is a town with fewer than 2,000 residents. Numerous other states can point to similar examples.

    Despite being presented with precise evidence of extreme corporate negligence, none of the executives from the top three distributors (McKesson, AmerisourceBergen, and Cardinal Health) admitted to contributing to the opioid epidemic during their testimonies before Congress last May.

    Instead, the chairman of the board of a much smaller private drug distributor, Miami-Luken, acknowledged its company’s complicity. That company’s role was much less scandalous. Miami-Luken shipped 20 million doses of oxycodone and hydrocodone to pharmacies in West Virginia between 2007 and 2012, whereas McKesson, AmerisourceBergen, and Cardinal Health were responsible for 423 million.

    Those three companies, which are ranked sixth, twelfth, and fourteenth respectively in the Fortune 500, can operate in this brazen manner for a few obvious reasons. They can easily withstand the relatively small fines assessed by various government agencies. The profits more than offset the costs.

    Also, they have the campaign financing and lobbying resources to wipe out any kind of credible threat to their opioid profits. Take for example what happened with the West Virginia attorney general, Patrick Morrisey.

    Morrisey claimed that he would recuse himself from an investigation of Cardinal Health due to his conflicts of interest, such as $8,000 of campaign donations and $250,000 from lobbying work for a trade group that represents Cardinal Health. Not to mention that his wife, Denise Henry, is a partner with the D.C. firm Capitol Counsel, which represented Cardinal Health from 1999 to 2016.

    Nonetheless, Patrick Morrisey met with representatives of Cardinal Health during the investigation that resulted in a $20 million settlement in 2016. Subsequently, a judge ordered Patrick Morrisey to release records of his communications with the company, but he hasn’t complied.

    It’s fairly obvious how campaign financing and lobbying can influence legislators. However, government agencies, such as the DEA, should theoretically be immune from this influence. That hasn’t been the case.

    There’s been a revolving door of former DEA agents who go on to assist the pharmaceutical industry in limiting the agency’s regulatory power. In fact, 42 former DEA officials are working at pharmaceutical companies or law firms that represent them, according to The Washington Post.

    That kind of influence certainly played a role in the DEA’s decision to allow the industry production quota for oxycodone to increase by 1,300 percent over a 20-year period. And the results have been disastrous. According to the CDC, there were nearly 218,000 deaths in the U.S. from prescription opioids from 1999 to 2017. The rate of death was five times higher in 2017 than in 1999.

    A bill passed in 2016, known as the “Ensuring Patient Access and Effective Drug Enforcement Act,” may have been the industry’s coup de grâce. Now the DEA’s ability to block drug companies from making suspicious transactions involving controlled substances is essentially nullified. And in the end, special interest groups were able to co-opt Congress for a low investment of $1.5 million. That price tag represents the cumulative donations by political action committees to the sponsors and cosponsors of the bill.

    So expect some seriously high-powered PR campaigns by the drug industry ahead of September’s trial. But don’t be swayed. These kinds of efforts are two decades too late and several billion dollars short. They can’t scrub the fact that these companies are complicit in the deaths of thousands of Americans.

    Brian Saady is the author of four books. That includes his series, Rackets, which chronicles the legalization of drugs and gambling, and the decriminalization of prostitution. You can check out his podcast and follow him on Facebook and Twitter.
     
  28. DUCKMOUTH

    DUCKMOUTH People don’t you know, don’t you know
    Donor
    Southern Mississippi Golden EaglesNew Orleans SaintsGrateful Dead

  29. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

  30. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

    Ain't no type of dope ever lasted nobody no three months
     
  31. Tony Ray Bans

    Tony Ray Bans Most Overlooked. Most Overbooked.
    Texas Tech Red RaidersDallas Cowboys

    I don't trust 10% of the junkies I used with to properly measure anything in microgram quantities. Heroin dealers have been using fent to turn a kilo of shit into hard hitting super H for years, the issue being that these dudes arent scientists and they fuck up more often than not.

    If we want a solution that involves them getting high, why not make suboxone legal for all docs to prescribe immediately or shit decriminalize and regulate heroin like they do in Europe.
     
    DUCKMOUTH likes this.
  32. blind dog

    blind dog Razorbacks
    Donor
    Arkansas RazorbacksSt. Louis CardinalsGreen Bay PackersTiger WoodsDallas Mavericks altBarAndGrillWu-tangCoors Light

  33. blotter

    blotter Aristocratic Bum
    Donor
    Florida State Seminoles

    In general opioid addicts knowing they have an affordable(or free) consistent dose available would help the problem tremendously. The idea of not having something is at times worse than the actual physical symptoms of addiction, but people have to plan with the anxiety of withdrawals looming. Makes the cycle that much more vicious. In addition to a bunch of other shit we should be administering decreasing doses in clinical settings. If people knew they had reliable sources they could hold jobs, not steal people's shit etc
     
    AlternativeFactsRule likes this.
  34. steamengine

    steamengine I don’t want to press one for English!
    Donor
    Texas Tech Red RaidersHouston AstrosHouston RocketsHouston DynamoLiverpoolTexas Tech Red Raiders altTravelHouston Oilers

  35. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

    Crazy levels of irony there, when you think about what part of the world original heroin came from
     
  36. TC

    TC Wake up, remember. We are born of one breath
    Donor
    South Carolina GamecocksSeattle Supersonics

    How the white collar dope dealers do it -- get reputable universities to say you're legit

    Tufts Will Investigate Its Ties to the Sackler Family. Here’s What Other Universities Are Doing.
    The Massachusetts attorney general, Maura Healey, has said that Purdue Pharma and its directors, including members of the Sackler family, used Tufts University to burnish their reputation and peddle the highly addictive painkiller OxyContin. Now Tufts officials say they will investigate whether that’s true.



    Anthony P. Monaco, the university’s president, announced on Monday that he had asked a former U.S. attorney, Donald K. Stern, to review a program on pain research that Purdue Pharma executives helped start at Tufts. According to a complaint filed by Healey in January, the company used that program to promote OxyContin in the medical and research communities.

    In a message to the Tufts campus, Monaco described the attorney general’s allegation that Purdue Pharma had used Tufts to “legitimize the marketing” of OxyContin as “deeply troubling.” He vowed to make any changes in university policies recommended as a result of the review.

    Monaco’s statement was among the most significant examples of a university weighing the ethics of its ties to the Sacklers, but Tufts is far from the only university that has accepted large donations from the family. Once known widely for their gifts to universities and museums, members of the Sackler family are becoming more closely associated with the source of their wealth: the painkiller that many blame for the opioid crisis.


    Following a series of news reports and lawsuits that have named individual Sacklers as defendants, several universities and cultural institutions have announced plans to review their connections to the family. Museums like the Guggenheim and the Tate have pledged not to accept any more money from the Sacklers. (Some members of Arthur M. Sackler’s family have tried to distance themselves from their relatives because he died before OxyContin came to market.) The chief executive of Purdue Pharma has said the company is considering bankruptcy.

    In a lawsuit against Purdue Pharma and members of the Sackler family who helped run the privately held company, Healey said the Tufts program, a master’s in pain research, education, and policy, had “brought Purdue name recognition, good will in the local and medical communities, and access to doctors at Massachusetts hospitals.” The program is aimed at physical therapists, nurses, pharmacists, and health-policy makers. It offers courses in topics like “the pharmacology of pain” and “sociocultural aspects of pain,” according to its website.

    Monaco said Stern and “a team of academic leaders” would review the program and other programs related to opioids that received funding from Purdue Pharma or Sackler family members. The goals, Monaco said, are to determine if the university had adhered to its policies and to judge whether those policies reflect best practices for research integrity and conflicts of interest.

    Tufts is also home to the Sackler School of Graduate Biomedical Sciences. According to Healey’s complaint, Purdue Pharma employees taught a seminar at Tufts, and Richard Sackler sat on the board of the Tufts University School of Medicine and “paid Tufts hundreds of thousands of dollars.”

    The Tufts Daily, the student newspaper, called for the university to cut ties with Purdue Pharma in an editorial in January. “Tufts has crossed a line past complicity,” the editorial said.


    Purdue Pharma has denied that it is responsible for the opioid crisis. The company is not the only maker of opioids, nor is it the only drug company being sued by attorneys general, as well as counties and municipalities across the country. In a statement to The Chronicle, a representative working for some members of the family said that court filings had created a false picture of the Sacklers, who remain committed to combating the opioid crisis.

    “For more than half a century, several generations of Sacklers have supported respected institutions that play crucial roles in health, research, education, the arts, and the humanities,” the statement said. “It has been a privilege to support the vital work of these organizations and we remain dedicated to doing so.”

    Tufts has not confirmed details of the Sackler family’s role in the pain-research program. “Tufts University has always been and remains deeply committed to the highest ethical and scientific standards in research and education,” a Tufts spokesman said in an emailed statement.

    The Defense Is in the Details
    How are the other universities that have received Sackler funds reacting? Some have barely acknowledged their connections to the family. But others are sifting through details about their Sackler gifts — how the money was used, which members of the family it came from — to guide their decisions on what, if anything, should change.

    After a review, the University of Connecticut decided it would keep its money — $4.5 million from Raymond and Beverly Sackler between 1985 and 2014. The Sacklers donated $3.1 million to the School of Medicine and $1.2 million to the School of Fine Arts, a university spokeswoman said. The Sacklers have made smaller gifts to the libraries and for scholarships for students from Stamford, Conn., where Purdue Pharma is based, among other programs.

    The spokeswoman said the university had determined that none of the Sackler funds “are connected to research, teaching, or programs related to opioids, pain management, the marketing of prescription opioids, or influencing what physicians prescribe.” Returning the money “would not undo the damage of the opioid crisis or punish the family or the company they are associated with,” and would only hurt UConn students and researchers, she said.

    Several other colleges have conducted reviews or continue to do so. Columbia University is home to the Sackler Institute for Developmental Psychobiology; its Sackler Institute Award supports research on psychiatric illness. A spokesman said the university had “re-evaluated accepting donations from the Sackler family’s philanthropies” and is not currently accepting donations from them.

    “Generosity from the Sackler family has funded issues core to Yale's mission.”
    The Yale Daily News, the student newspaper at Yale University, reported that the Sacklers had endowed professorships, including $3 million for the Richard Sackler and Jonathan Sackler Professorship, and had funded the Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences, among other gifts. Peter Salovey, the president, told the newspaper that while the opioid-addiction crisis is real, “generosity from the Sackler family has funded issues core to Yale’s mission.” He said he would not comment further before consulting with faculty members and deans.

    A Yale spokeswoman said that the university is “aware of the ongoing efforts to determine potential contributing factors in the current opioid epidemic, including through legal processes, and will continue to monitor the outcomes of those efforts.” She said that many researchers at Yale are working on causes and treatments for addiction.


    Brown University received a pledge for a Sackler donation in 2016. The university has not spent the gift, and plans to do so are on pause, a Brown spokesman said. The university did not disclose the value of the gift but included it on a list of donations of $1 million or more.

    At Harvard University, the Arthur M. Sackler Museum, which houses Asian, Middle Eastern, and Mediterranean art, has become a flashpoint. Protesters held a “die-in” last summer at the museum, where they lay on the floor surrounded by empty pill bottles. Nearly 15,000 people have signed a petition calling on Harvard to cut ties with the Sacklers.


    “Harvard does not have plans to remove Dr. Sackler's name from the museum.”
    A museum spokesman said in a statement that funds for the construction of the museum’s former building were donated in 1982 by Arthur Sackler, who died in 1987, before OxyContin was developed.

    “Given these circumstances and legal and contractual considerations, Harvard does not have plans to remove Dr. Sackler’s name from the museum,” the statement said.

    In an essay for ArtNet News, an artist who is a member of the Council for Feminist Art at the Elizabeth A. Sackler Center for Feminist Art argued that the branch of the Sackler family descended from Arthur should not be lumped in with those who developed and profited from OxyContin. According to a recent Esquire report, though, it was Arthur who pioneered the aggressive marketing tactics, albeit with different drugs, that were later deployed for OxyContin.

    Donations Across the Country
    The Massachusetts attorney general’s complaint said that in addition to the donations to Tufts, in 2010 Purdue Pharma gave $50,000 to Boston University for a “program on opioid prescribing for chronic pain” and $15,000 to Northeastern University for a program on pain management. A Boston University spokeswoman said the institution had received “a modest donation for a lecture series,” and “those funds have been expended.” A spokeswoman for Northeastern said that she could not find any record that the university had received a donation from the Sackler family or Purdue Pharma for research or study in the past 10 years.

    A spokeswoman at Weill Cornell Medicine, Cornell University’s medical school in New York City, did not return a request for comment on the university’s Sackler Institute for Developmental Psychobiology in time for publication.

    The California Institute of Technology and the University of California at Los Angelesreceived a joint gift from the Sackler Foundation to fund biomedical science research in 2012. Caltech said it had not received a gift from the Sacklers in the past five years, and a UCLA spokesman did not respond to a request for comment.

    At New York University, home to the Sackler Institute of Graduate Biomedical Sciences, students have held demonstrations and asked the university to commit to not accepting any more money from the family. Artforum reported in July that NYU had told a student activist that the university is “in negotiations with the Sacklers about the name of the program.” In a statement, a spokeswoman for the NYU School of Medicine said that the institution is “not accepting donations from the Sackler family or any Sackler-related entities.”

    So far, no university has said it will give back Sackler donations or remove the Sackler name from its buildings or programs. Calls for institutions to do so haven’t reached the pitch of some other campus protests. But the legal pressures on the Sacklers, and therefore the news reports about the family’s history, show no signs of abating. And still, an average of 130 people per day are dying from opioid overdoses.

    https://www.chronicle.com/article/Tufts-Will-Investigate-Its/245976
     
  37. Capstone 88

    Capstone 88 Going hard in the paint
    Donor
    Alabama Crimson TideAtlanta BravesTennessee TitansNashville Predators2pac

    #488 Capstone 88, Mar 26, 2019
    Last edited: Mar 26, 2019
  38. ShuPoor

    ShuPoor I know my sins will take me to hell
    Donor
    Tulsa Golden HurricaneOklahoma City Thunder

    Huh. Sometimes Oklahoma surprises me.
     
  39. Bruce Wayne

    Bruce Wayne Billionaire Playboy
    Donor
    Michigan Wolverines

  40. Tony Ray Bans

    Tony Ray Bans Most Overlooked. Most Overbooked.
    Texas Tech Red RaidersDallas Cowboys

    The Sacklers are such trash human beings
     
    BudKilmer likes this.
  41. southlick

    southlick "Better Than You"
    Donor TMB OG
    Alabama Crimson TideAtlanta BravesDallas CowboysBirmingham Legion

  42. southlick

    southlick "Better Than You"
    Donor TMB OG
    Alabama Crimson TideAtlanta BravesDallas CowboysBirmingham Legion

  43. lechnerd

    lechnerd They say Monaco is a sunny place for shady people
    Donor
    Texas AandM Aggies alt

    How do I get bribed with strippers and steak?
     
  44. southlick

    southlick "Better Than You"
    Donor TMB OG
    Alabama Crimson TideAtlanta BravesDallas CowboysBirmingham Legion

    [​IMG]
     
    TC likes this.
  45. dblplay1212

    dblplay1212 Well-Known Member
    Donor TMB OG
    Alabama Crimson TideNew York YankeesJacksonville JaguarsTiger Woods2pacSneakersWu-tang

  46. Taques

    Taques let's mosey
    Staff Donor TMB OG
    Texas Tech Red RaidersBoston CelticsManchester CityTorinoNew Mexico UnitedPCd'I

    posting from the sackler library right now

    crazy
     
  47. dblplay1212

    dblplay1212 Well-Known Member
    Donor TMB OG
    Alabama Crimson TideNew York YankeesJacksonville JaguarsTiger Woods2pacSneakersWu-tang

  48. Zebbie

    Zebbie Hey Mike, guess what I have in my underwear?
    Donor
    Texas Tech Red RaidersTexas RangersChicago CubsLos Angeles ChargersTexas Tech Red Raiders alt

    I’ve never understood how that didn’t set off alarm bells all over the place - that’s just insane.
     
  49. dblplay1212

    dblplay1212 Well-Known Member
    Donor TMB OG
    Alabama Crimson TideNew York YankeesJacksonville JaguarsTiger Woods2pacSneakersWu-tang

    How is that pharmacist not rotting in jail? You can get caught selling an ounce of coke and go to jail for a long time but apparently selling 4.5m pills in a a year in a town of 392 people is cool.